A federal jury in New Orleans deliberated for less than two hours before coming back this week with a defense win in the first bellwether trial over the blood thinner Xarelto.

That's a bona fide slam dunk–even for lead defense counsel Beth Wilkinson, who's notched a streak of trial victories in her career. But it's not surprising to Wilkinson, whose previous trials also included juries that have come back quickly.

“If you can make your case really clear, so the jury from opening to closings knows what you're saying, it makes it easier to go back and come to a consensus,” said Wilkinson, of Washington, D.C.'s Wilkinson Walsh + Eskovitz, who led a Xarelto trial team that included David Dukes, a partner at Nelson Mullins Riley & Scarborough in Columbia, South Carolina, and Richard Sarver of Barrasso Usdin Kupperman Freeman & Sarver in New Orleans.